Loading chat...
FL H0171
Bill
Status
Introduced
1/4/2019
Primary Sponsor
Health Quality Subcommittee
Click for details
AI Summary
- County commissions may authorize sterile needle and syringe exchange programs within their boundaries to prevent transmission of HIV, AIDS, viral hepatitis, and other blood-borne diseases among intravenous drug users
- Programs must operate on a one-to-one exchange basis, provide educational materials on disease transmission, offer drug abuse counseling/treatment referrals, HIV/hepatitis screening, and emergency opioid antagonist kits
- Eligible program operators include licensed hospitals, health care clinics, accredited medical schools, licensed addiction receiving facilities, and nonprofit HIV/AIDS service organizations qualifying under 501(c)(3)
- Programs must be funded entirely through private grants and donations; no state, county, or municipal funds may be used
- Annual reports due August 1 to county commissions and the Department of Health, with a statewide compilation report due October 1 to the Governor and Legislature
Legislative Description
Infectious Disease Elimination Programs
Last Action
Laid on Table, companion bill(s) passed, see CS/CS/SB 366 (Ch. 2019-143)
4/17/2019
Committee Referrals
Health And Human Services4/3/2019
Judiciary3/28/2019
Health Quality Subcommittee1/16/2019
Full Bill Text
No bill text available